Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Odika J, Apollo"'
Autor:
Bernhards R Ogutu, Odika J Apollo, Denise McKinney, Willis Okoth, Joram Siangla, Filip Dubovsky, Kathryn Tucker, John N Waitumbi, Carter Diggs, Janet Wittes, Elissa Malkin, Amanda Leach, Lorraine A Soisson, Jessica B Milman, Lucas Otieno, Carolyn A Holland, Mark Polhemus, Shon A Remich, Christian F Ockenhouse, Joe Cohen, W Ripley Ballou, Samuel K Martin, Evelina Angov, V Ann Stewart, Jeffrey A Lyon, D Gray Heppner, Mark R Withers, MSP-1 Malaria Vaccine Working Group
Publikováno v:
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
The antigen, falciparum malaria protein 1 (FMP1), represents the 42-kDa C-terminal fragment of merozoite surface protein-1 (MSP-1) of the 3D7 clone of P. falciparum. Formulated with AS02 (a proprietary Adjuvant System), it constitutes the FMP1/AS02 c
Externí odkaz:
https://doaj.org/article/656dad9481c241c485519a092be610e9
Autor:
Bernhards R, Ogutu, Odika J, Apollo, Denise, McKinney, Willis, Okoth, Joram, Siangla, Filip, Dubovsky, Kathryn, Tucker, John N, Waitumbi, Carter, Diggs, Janet, Wittes, Elissa, Malkin, Amanda, Leach, Lorraine A, Soisson, Jessica B, Milman, Lucas, Otieno, Carolyn A, Holland, Mark, Polhemus, Shon A, Remich, Christian F, Ockenhouse, Joe, Cohen, W Ripley, Ballou, Samuel K, Martin, Evelina, Angov, V Ann, Stewart, Jeffrey A, Lyon, D Gray, Heppner, Mark R, Withers, Mark, Fukuda
Publikováno v:
PLoS ONE
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
PLoS ONE, Vol 4, Iss 3, p e4708 (2009)
Objective The antigen, falciparum malaria protein 1 (FMP1), represents the 42-kDa C-terminal fragment of merozoite surface protein-1 (MSP-1) of the 3D7 clone of P. falciparum. Formulated with AS02 (a proprietary Adjuvant System), it constitutes the F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b51c2f33411b63a9c58027e911102163
https://pubmed.ncbi.nlm.nih.gov/19262754
https://pubmed.ncbi.nlm.nih.gov/19262754
Autor:
José A. Stoute, Joe Cohen, Shon Remich, Janet Wittes, Carter L. Diggs, Carolyn A. Holland, Filip Dubovsky, Odika J. Apollo, Samuel K. Martin, Mark R. Withers, W. Ripley Ballou, Bernhards Ogutu, Lorraine Soisson, Amanda J. Leach, D. Gray Heppner, Denise McKinney, Jessica Milman, Jeffrey A. Lyon, V. Ann Stewart, Kathryn Tucker, John N. Waitumbi, Evelina Angov, Otieno G Allen
Publikováno v:
PLoS Clinical Trials
Objective: Our aim was to evaluate the safety, reactogenicity, and immunogenicity of an investigational malaria vaccine. Design: This was an age-stratified phase Ib, double-blind, randomized, controlled, dose-escalation trial. Children were recruited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f92f9c92ec49236ac49d073121262548
https://doi.org/10.1371/journal.pctr.0010032
https://doi.org/10.1371/journal.pctr.0010032